In colorectal cancer cells, for instance, promoter methylation of the class II transactivator (CIITA) gene impairs IFN-γ-induced CIITA expression, thereby blocking MHC class II upregulation and reducing CD4+T cell recognition [65]. This evidence concerns the gene CIITA and colorectal cancer.